Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do Hedge Funds Think of Eastman Chemical Company (EMN)?

Page 1 of 2

Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition to our portfolios. The odds are not exactly stacked in investors’ favor when it comes to beating the market, as evidenced by the fact that less than 49% of the stocks in the S&P 500 did so during the 12-month period ending October 30. However, 63% of hedge funds’ top 30 stock picks from the index did beat the market, and returned nearly twice as much on average as the index. Thus, we can see that the tireless research and efforts of hedge funds to identify winning stocks can work to our advantage when we know how to use the data. While not all of their picks will be winners, our odds are much better following their best stock picks than trying to go it alone.

Eastman Chemical Company (NYSE:EMN) investors should be aware of a decrease in enthusiasm from smart money recently. EMN was in 37 hedge funds’ portfolios at the end of the third quarter of 2015. There were 39 hedge funds in our database with EMN positions at the end of the previous quarter. At the end of this article we will also compare EMN to other stocks including C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), Autoliv Inc. (NYSE:ALV), and IMS Health Holdings Inc (NYSE:IMS) to get a better sense of its popularity.

Follow Eastman Chemical Co (NYSE:EMN)
Trade (NYSE:EMN) Now!

Now, let’s check out the new action regarding Eastman Chemical Company (NYSE:EMN).

Hedge fund activity in Eastman Chemical Company (NYSE:EMN)

At the end of the third quarter, a total of 37 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -5% from the previous quarter. With the smart money’s sentiment swirling, there exists a few notable hedge fund managers who were increasing their stakes meaningfully (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, David Cohen and Harold Levy’s Iridian Asset Management has the number one position in Eastman Chemical Company (NYSE:EMN), worth close to $362.4 million, accounting for 3.1% of its total 13F portfolio. The second largest stake is held by Ivory Capital (Investment Mgmt), managed by Curtis Macnguyen, which holds an $91.1 million position; the fund has 2.4% of its 13F portfolio invested in the stock. Remaining peers that hold long positions include Leon Cooperman’s Omega Advisors, David Tepper’s Appaloosa Management LP and Ken Griffin’s Citadel Investment Group.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!